Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Blair

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature Reviews. Rheumatology|September 22, 2010
Regulatory B cells in autoimmunity: developments and controversiesClaudia Mauri, Paul A Blair
Immunity|December 20, 2014
The incognito journey of a regulatory B cellClaudia Mauri, Paul A Blair
Molecular Immunology|February 22, 2014
Cellular targets of regulatory B cell-mediated suppressionElizabeth C Rosser, Paul A Blair, Claudia Mauri
Immunity|March 13, 2016
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus ErythematosusMadhvi Menon, Paul A Blair, David A Isenberg, et al.
Clinical Immunology (Orlando, Fla.)|August 2, 2015
Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiationMarcela Vlkova, Olga Ticha, Jana Nechvatalova, et al.
Immunity|January 19, 2010
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patientsPaul A Blair, Lina Yassin Noreña, Fabian Flores-Borja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr micePaul A Blair, Karina A Chavez-Rueda, Jamie G Evans, et al.
Thrombosis and Haemostasis|June 12, 2015
B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10Asa C Strom, Amanda J Cross, Jennifer E Cole, et al.
European Journal of Immunology|November 20, 2014
Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survivalAurélie Moreau, Paul A Blair, Jian-Guo Chai, et al.
The Journal of Clinical Investigation|August 10, 2018
Circulating and intrahepatic antiviral B cells are defective in hepatitis BAlice R Burton, Laura J Pallett, Laura E McCoy, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature Reviews. Rheumatology|September 22, 2010
Regulatory B cells in autoimmunity: developments and controversiesClaudia Mauri, Paul A Blair
Immunity|December 20, 2014
The incognito journey of a regulatory B cellClaudia Mauri, Paul A Blair
Molecular Immunology|February 22, 2014
Cellular targets of regulatory B cell-mediated suppressionElizabeth C Rosser, Paul A Blair, Claudia Mauri
Immunity|March 13, 2016
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus ErythematosusMadhvi Menon, Paul A Blair, David A Isenberg, et al.
Clinical Immunology (Orlando, Fla.)|August 2, 2015
Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiationMarcela Vlkova, Olga Ticha, Jana Nechvatalova, et al.
Immunity|January 19, 2010
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patientsPaul A Blair, Lina Yassin Noreña, Fabian Flores-Borja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr micePaul A Blair, Karina A Chavez-Rueda, Jamie G Evans, et al.
Thrombosis and Haemostasis|June 12, 2015
B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10Asa C Strom, Amanda J Cross, Jennifer E Cole, et al.
European Journal of Immunology|November 20, 2014
Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survivalAurélie Moreau, Paul A Blair, Jian-Guo Chai, et al.
The Journal of Clinical Investigation|August 10, 2018
Circulating and intrahepatic antiviral B cells are defective in hepatitis BAlice R Burton, Laura J Pallett, Laura E McCoy, et al.
Pageof 2